Guru Ownership Trend
Guru Analysis for KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. (KALV), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $65.88 M.
Top institutional holders include Steven Cohen and Jefferies Group.
Institutional sentiment is currently Bullish. This is evidenced by a $395,107.63 net inflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Steven Cohen reduced exposure by 6.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for KalVista Pharmaceuticals, Inc. (KALV)
Major holders include Steven Cohen ($43.02 M), Jefferies Group ($5.76 M), Cliff Asness ($756,325). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.46 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $395,107.63, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited KALV. The total reported sell value was $5.62 M.
Yes, 1 managers opened new positions in KALV, and 1 increased their existing holdings. The total reported buy value was $6.02 M.